Loss of PINK 1 Increases the Heart ’ s Vulnerability to Ischemia-Reperfusion Injury

Objectives: Mutations in PTEN inducible kinase-1 (PINK1) induce mitochondrial dysfunction in dopaminergic neurons resulting in an inherited form of Parkinson’s disease. Although PINK1 is present in the heart its exact role there is unclear. We hypothesized that PINK1 protects the heart against acute ischemia reperfusion injury (IRI) by preventing mitochondrial dysfunction. Methods and Results: Over-expressing PINK1 in HL-1 cardiac cells reduced cell death following simulated IRI (29.265.2% PINK1 versus 49.062.4% control; N = 320 cells/group P,0.05), and delayed the onset of mitochondrial permeability transition pore (MPTP) opening (by 1.3 fold; P,0.05). Hearts excised from PINK1+/+, PINK1+/2 and PINK12/2 mice were subjected to 35 minutes regional ischemia followed by 30 minutes reperfusion. Interestingly, myocardial infarct size was increased in PINK12/2 hearts compared to PINK1+/+ hearts with an intermediate infarct size in PINK1+/2 hearts (25.162.0% PINK1+/+, 38.963.4% PINK1+/2 versus 51.564.3% PINK12/2 hearts; N.5 animals/group; P,0.05). Cardiomyocytes isolated from PINK12/2 hearts had a lower resting mitochondrial membrane potential, had inhibited mitochondrial respiration, generated more oxidative stress during simulated IRI, and underwent rigor contracture more rapidly in response to an uncoupler when compared to PINK1+/+ cells suggesting mitochondrial dysfunction in hearts deficient in PINK1. Conclusions: We show that the loss of PINK1 increases the heart’s vulnerability to ischemia-reperfusion injury. This may be due, in part, to increased mitochondrial dysfunction. These findings implicate PINK1 as a novel target for cardioprotection. Citation: Siddall HK, Yellon DM, Ong S-B, Mukherjee UA, Burke N, et al. (2013) Loss of PINK1 Increases the Heart’s Vulnerability to Ischemia-Reperfusion Injury. PLoS ONE 8(4): e62400. doi:10.1371/journal.pone.0062400 Editor: Rakesh Kukreja, Virginia Commonwealth University Medical Center, United States of America Received September 28, 2012; Accepted March 21, 2013; Published April 29, 2013 Copyright: 2013 Siddall et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: This work was supported by the British Heart Foundation grant number FS/06/023 and supported by researchers at the National Institute for Health Research University College London Hospitals Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist. * E-mail: d.hausenloy@ucl.ac.uk

[1]  Nicholas W Wood,et al.  Cell metabolism affects selective vulnerability in PINK1-associated Parkinson's disease , 2011, Journal of Cell Science.

[2]  V. Giorgio,et al.  The mitochondrial permeability transition pore and cyclophilin D in cardioprotection. , 2011, Biochimica et biophysica acta.

[3]  T. Mak,et al.  PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function , 2011, Proceedings of the National Academy of Sciences.

[4]  Sang-Bing Ong,et al.  Inhibiting Mitochondrial Fission Protects the Heart Against Ischemia/Reperfusion Injury , 2010, Circulation.

[5]  Angela C. Poole,et al.  The Mitochondrial Fusion-Promoting Factor Mitofusin Is a Substrate of the PINK1/Parkin Pathway , 2010, PloS one.

[6]  A. Whitworth,et al.  Drosophila Parkin requires PINK1 for mitochondrial translocation and ubiquitinates Mitofusin , 2010, Proceedings of the National Academy of Sciences.

[7]  H. Büeler Mitochondrial dynamics, cell death and the pathogenesis of Parkinson’s disease , 2010, Apoptosis.

[8]  Q. Wan,et al.  Regulation of PINK1 by NR2B‐containing NMDA receptors in ischemic neuronal injury , 2009, Journal of neurochemistry.

[9]  David S. Park,et al.  Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial Fission* , 2009, Journal of Biological Chemistry.

[10]  P. Verstreken,et al.  Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function , 2009, EMBO molecular medicine.

[11]  A. Halestrap Mitochondria and reperfusion injury of the heart—A holey death but not beyond salvation , 2009, Journal of bioenergetics and biomembranes.

[12]  Michael R. Duchen,et al.  PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell Death , 2009, Molecular cell.

[13]  M. Mocanu,et al.  Mitochondrial PINK1—A Novel Cardioprotective Kinase? , 2008, Cardiovascular Drugs and Therapy.

[14]  William Stanley,et al.  Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation , 2008, Cardiovascular research.

[15]  Jie Shen,et al.  Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress , 2008, Proceedings of the National Academy of Sciences.

[16]  M. Mocanu,et al.  Ischemia-reperfusion injury and cardioprotection: investigating PTEN, the phosphatase that negatively regulates PI3K, using a congenital model of PTEN haploinsufficiency , 2008, Basic Research in Cardiology.

[17]  S. Tabrizi,et al.  PINK1 Is Necessary for Long Term Survival and Mitochondrial Function in Human Dopaminergic Neurons , 2008, PloS one.

[18]  D. Yellon,et al.  The novel adipocytokine visfatin exerts direct cardioprotective effects , 2008, Journal of cellular and molecular medicine.

[19]  T. Yeh,et al.  PINK1 mutants associated with recessive Parkinson’s disease are defective in inhibiting mitochondrial release of cytochrome c , 2007, Neurobiology of Disease.

[20]  R. Dixon,et al.  Temporal Changes in Myocardial Salvage Kinases During Reperfusion Following Ischemia: Studies Involving the Cardioprotective Adipocytokine Apelin , 2007, Cardiovascular Drugs and Therapy.

[21]  J. Olzmann,et al.  PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1 , 2007, PLoS biology.

[22]  Michael S Janes,et al.  Selective fluorescent imaging of superoxide in vivo using ethidium-based probes , 2006, Proceedings of the National Academy of Sciences.

[23]  Li Qian,et al.  Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila , 2006, Proceedings of the National Academy of Sciences.

[24]  Sunhong Kim,et al.  Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin , 2006, Nature.

[25]  Changan Jiang,et al.  Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin , 2006, Nature.

[26]  M. Duchen,et al.  Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. , 2006, The international journal of biochemistry & cell biology.

[27]  P. S. St George-Hyslop,et al.  Wild-type PINK1 Prevents Basal and Induced Neuronal Apoptosis, a Protective Effect Abrogated by Parkinson Disease-related Mutations* , 2005, Journal of Biological Chemistry.

[28]  M. Duchen,et al.  Preconditioning protects by inhibiting the mitochondrial permeability transition. , 2004, American journal of physiology. Heart and circulatory physiology.

[29]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[30]  X. Leverve,et al.  Opening of the Mitochondrial Permeability Transition Pore Induces Reactive Oxygen Species Production at the Level of the Respiratory Chain Complex I* , 2004, Journal of Biological Chemistry.

[31]  C. Ganote,et al.  Effects of CCCP-induced mitochondrial uncoupling and cyclosporin A on cell volume, cell injury and preconditioning protection of isolated rabbit cardiomyocytes. , 2003, Journal of molecular and cellular cardiology.

[32]  D. Yellon,et al.  The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. , 2003, Journal of molecular and cellular cardiology.

[33]  Yusuke Nakamura,et al.  Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway , 2001, Oncogene.

[34]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[35]  Steven J. Sollott,et al.  Reactive Oxygen Species (Ros-Induced) Ros Release , 2000, The Journal of experimental medicine.

[36]  N J Izzo,et al.  HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  C. Marsden,et al.  Mitochondrial Complex I Deficiency in Parkinson's Disease , 1990, Lancet.

[38]  B. Stokes,et al.  Energy depletion-repletion and calcium transients in single cardiomyocytes. , 1989, The American journal of physiology.

[39]  K. Kako,et al.  Oxidant injury to isolated heart cells. , 1989, The Canadian journal of cardiology.

[40]  M. Duchen,et al.  Assessing mitochondrial potential, calcium, and redox state in isolated mammalian cells using confocal microscopy. , 2007, Methods in molecular biology.